OMIC
Income statement / Annual
Last year (2023), Singular Genomics Systems, Inc.'s total revenue was $2.91 M,
an increase of 280.52% from the previous year.
In 2023, Singular Genomics Systems, Inc.'s net income was -$94.82 M.
See Singular Genomics Systems, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$2.91 M
|
$765,000.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$3.47 M |
$789,000.00 |
$1.13 M |
$639,000.00 |
$350,000.00 |
Gross Profit |
-$558,000.00 |
-$24,000.00 |
-$1.13 M |
-$639,000.00 |
-$350,000.00 |
Gross Profit Ratio |
-0.19 |
-0.03 |
0 |
0 |
0 |
Research and Development
Expenses |
$47.76 M
|
$46.20 M
|
$32.66 M
|
$21.25 M
|
$10.48 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$6.29 M
|
$2.29 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$54.48 M
|
$47.26 M
|
$28.62 M
|
$6.29 M
|
$2.29 M
|
Other Expenses |
$0.00 |
$0.00 |
$405,000.00 |
$0.00 |
$0.00 |
Operating Expenses |
$102.24 M |
$93.46 M |
$61.28 M |
$27.53 M |
$12.77 M |
Cost And Expenses |
$105.71 M |
$94.25 M |
$61.28 M |
$27.53 M |
$12.77 M |
Interest Income |
$9.08 M |
$3.37 M |
$328,000.00 |
$505,000.00 |
$463,000.00 |
Interest Expense |
$1.10 M |
$763,000.00 |
$846,000.00 |
$718,000.00 |
$17,000.00 |
Depreciation &
Amortization |
$7.22 M
|
$6.03 M
|
$1.13 M
|
$639,000.00
|
$350,000.00
|
EBITDA |
-$86.50 M
|
-$90.12 M
|
-$60.55 M
|
-$26.39 M
|
-$11.96 M
|
EBITDA Ratio |
-29.71 |
-117.8 |
0 |
0 |
0 |
Operating Income Ratio
|
-35.31
|
-122.21
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$7.98 M
|
$2.61 M
|
-$37.49 M
|
-$411,000.00
|
$446,000.00
|
Income Before Tax |
-$94.82 M |
-$90.88 M |
-$98.77 M |
-$27.95 M |
-$12.32 M |
Income Before Tax Ratio
|
-32.57
|
-118.8
|
0
|
0
|
0
|
Income Tax Expense |
$9.08 M |
-$2.61 M |
$118,000.00 |
$718,000.00 |
$17,000.00 |
Net Income |
-$94.82 M |
-$88.27 M |
-$98.89 M |
-$28.66 M |
-$12.34 M |
Net Income Ratio |
-32.57 |
-115.39 |
0 |
0 |
0 |
EPS |
-39.08 |
-37.22 |
-40.95 |
-12.41 |
-5.34 |
EPS Diluted |
-39.08 |
-37.22 |
-40.95 |
-12.41 |
-5.34 |
Weighted Average Shares
Out |
$2.43 M
|
$2.37 M
|
$2.41 M
|
$2.31 M
|
$2.31 M
|
Weighted Average Shares
Out Diluted |
$2.43 M
|
$2.37 M
|
$2.41 M
|
$2.31 M
|
$2.31 M
|
Link |
|
|
|
|
|